Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial.

Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio

http://www.ncbi.nlm.nih.gov/pubmed/42604730

Anna Hultberg; Damien Chimits; Filip Matthijssens; Francesco Zaja; Hanny T Al-Samkari; Jaume Ayguasanosa; Kaichi Nishiwaki; Peter Ulrichts; Sylvian Audia; Yoshitaka Miyakawa

Aug 17, 2026